 |
|
|
| |
Pharmacokinetics, Safety and Antiviral Activity of Fosamprenavir-Containing Regimens in HIV-Infected 2 to 18 Year-Old Children (48-Week Data, Study APV29005, a Prospective, Open-label, Multi-centre, 48-Week Cohort Study)
|
| |
| |
Reported by Jules Levin
19th IAC Wash DC USA July 22-27 2012
E Voronin,1 C Fortuny,2 D Perez-Tamarit,3 D Duiculescu,4 M Cotton,5 L Ross,6 S Ford,6 N Givens,7 K Cheng,7 J Sievers7
1Republic Hospital of Infectious Disease, St Petersburg, Russian Federation; 2Sant Joan de Deu Hospital, Barcelona, Spain; 3Hospital Infantil La Fe, Valencia, Spain; 4Dr Victor Babes Hospital for Infectious and Tropical Diseases, Bucharest, Romania; 5Tygerberg Children's Hospital, Tygerberg, South Africa; 6GlaxoSmithKline, Research Triangle Park, NC, United States; 7GlaxoSmithKline, Uxbridge, United Kingdom
|
| |
|
|
|
|
|
